
Sign up to save your podcasts
Or


This week in clinical cardiology.
PCI reduces mortality after STEMI in older adults.
Canagliflozin lowers kidney failure risk in T2D: CREDENCE.
Poor response to statins hikes risk of cardiovascular events.
Low LDL cholesterol may increase women's risk of hemorrhagic stroke
This week in clinical cardiology:
You can contact the Cardiocast with ideas, suggestions, stories, or questions for Dr. Dwyer by emailing us at [email protected] and you can follow MDedge Cardiology on Twitter at @MDedgeCardio.
This week's top stories in clinical cardiology:
Has radial access PCI been overhyped?
Hospital TAVR volume matters to patient survival.
Studies link TMAO to microbiome, reveal new heart disease target.
More chest compression–only CPR leads to increased survival rates.
You can contact the show by emailing us at [email protected] or you can follow MDedge Cardiology on Twitter at @MDedgeCardio.
This week, a novel drug that reverses ticagrelor's effect looks promising, a new certification process for cardiologists is unveiled, intensive blood pressure monitoring may not help prevent a second stroke, and the FDA cautions against using paclitaxel coated devices.
Cardiovascular prevention guidelines downgrade aspirin, high coronary artery calcium scores carry greater risks, an Apple Watch algorithm predicts AFib, and TAVR overtakes surgery in "historic" trials.
This week in MDedge Cardiocast: A novel drug lowers LDL in on top of maximums statins, invasive cardiology is a top money maker for hospitals, a meta-analysis parses the heart and kidney benefits of new diabetes drugs, and the AHA warns that heart-harming toxins may hurt hookah smokers.
This week in MDedge Cardiocast: Infective endocarditis isn't what it used to be, there's a new, lower goal for Americans' dietary intake of sodium, a drug to treat myeloma also raises heart failure risk, and Big Pharma says it can't drop drug list prices alone.
The Food and Drug Administration could extend eligibility for Belviq to lower-risk patients, the agency says a popular gout drug raises cardiovascular risk, an AHA statement targets CV risk factors in children, and a class action suit against the American Board of Internal Medicine over MOC gets financial support from doctors.
Silent strokes are common after noncardiac surgery, troubling news about nonadherence to statins, what cardiologists need to know about ARVC, and how gender inequality in medicine affects the health of all women.
This week in MDedge Cardiocast: Most tPA-eligible stroke patients now get treated within an hour, LAA closure can be treated safely in patients with prior hemorrhagic stroke, SGLT2 inhibitors are quickly morphing from diabetes to heart failure drugs, and the MESA cardiovascular disease risk calculator can be an improvement on the ACC/AHA version.
From the publisher's feed